2026 NPPES data Ophthalmology Physician NPI 1679571798 M.D.
Verify on CMS →

MONA BHAN, M.D.

Ophthalmology Physician in FRAMINGHAM, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
978
Medicare Part D claims · 279 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$560.71
36 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MONA BHAN, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 978 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
978
Part D claims, 2023
67%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MONA BHAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MONA BHAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MONA BHAN, M.D.?

Below national average

NPI registry status

Active

Issued 07/12/2005

NPI 1679571798

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

978 31% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Ophthalmology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Ophthalmology Physician share within Massachusetts

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Massachusetts

Medicare quality performance — MIPS

MONA BHAN, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Ophthalmology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MONA BHAN, M.D. is a Ophthalmology Physician provider practicing in FRAMINGHAM, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1679571798. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MONA BHAN, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 61 LINCOLN ST, FRAMINGHAM, MA, 01702, with a listed phone of (508) 620-0017. NPI 1679571798 was issued on 07/12/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 978 prescription claims written by this provider, covering 279 Medicare beneficiaries and totaling roughly $154K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

61 LINCOLN ST
FRAMINGHAM, MA 01702

Provider Details

NPI 1679571798
Specialty Ophthalmology Physician
Credentials M.D.
Gender Female
NPI Issued 07/12/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MONA BHAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$561

Largest payer

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MONA BHAN, M.D.. To verify MONA BHAN, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MONA BHAN, M.D. — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 978 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

978
Total Claims
$154K
Total Drug Cost
279
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,862
Total Day Supply
51,796
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$131K
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
77.7 years
Avg HCC Risk Score
1.28
Gender Split
68% female / 32% male
Age Distribution
<65: 14, 65-74: 82, 75-84: 124, 85+: 59

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
322
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
100
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
69
Timolol Maleate
69
Prednisolone Acetate
61
Lumigan
Bimatoprost
54
Brimonidine Tartrate
32
Ofloxacin
32
Erythromycin
Erythromycin Base
30
Restasis
Cyclosporine
30

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MONA BHAN, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MONA BHAN, M.D.'s 978 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as BHAN.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MONA BHAN, M.D.'s specialty?
MONA BHAN, M.D. specializes in Ophthalmology Physician and practices in FRAMINGHAM, Massachusetts. Credentials: M.D..
How much does MONA BHAN, M.D. prescribe under Medicare Part D?
In 2023, MONA BHAN, M.D. wrote 978 Medicare Part D claims totaling $154K in drug costs for 279 beneficiaries.
What is MONA BHAN, M.D.'s Medicare quality score?
MONA BHAN, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MONA BHAN, M.D. located?
MONA BHAN, M.D. is located at 61 LINCOLN ST, FRAMINGHAM, MA, 01702. Phone: (508) 620-0017.
What is MONA BHAN, M.D.'s NPI number?
MONA BHAN, M.D.'s National Provider Identifier (NPI) is 1679571798, issued on 07/12/2005.
Does MONA BHAN, M.D. prescribe more brand-name or generic drugs?
MONA BHAN, M.D.'s prescribing is 33% brand-name and 67% generic drugs by claim count, with $131K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MONA BHAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MONA BHAN, M.D.'s most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MONA BHAN, M.D. accept Medicare?
MONA BHAN, M.D. appears in CMS Medicare data with 978 Part D claims and 279 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MONA BHAN, M.D.'s credentials?
MONA BHAN, M.D.'s NPI is 1679571798 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology